ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.768,96
0,33%
S&P 500
5.308,13
0,09%
Dow Jones
39.806,77
-0,49%
Euro vs US Dollar
1,0859
-0,01%
Bitcoin
71.016,28
-0,61%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NYSE
  6. Nevro Corp (NVRO)

  7. Nevro Corp (NVRO) News

NVRO

Nevro (NVRO)

Nevro Corp
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NYSE:NVRO
DatumZeitQuelleÜberschriftSymbolFirma
17/05/202422h40Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:NVRONevro Corp
09/05/202422h52Edgar (US Regulatory)Form 8-K - Current reportNYSE:NVRONevro Corp
09/05/202422h05PR Newswire (US)Nevro to Present at BofA Securities 2024 Healthcare ConferenceNYSE:NVRONevro Corp
07/05/202422h56Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:NVRONevro Corp
07/05/202422h11Edgar (US Regulatory)Form 8-K - Current reportNYSE:NVRONevro Corp
07/05/202422h05PR Newswire (US)Nevro Reports First-Quarter 2024 Financial ResultsNYSE:NVRONevro Corp
17/04/202414h30PR Newswire (US)Nevro to Report First-Quarter 2024 Financial Results and Host Earnings Conference Call on May 7, 2024NYSE:NVRONevro Corp
11/03/202421h53Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NVRONevro Corp
11/03/202421h52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NVRONevro Corp
11/03/202421h51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NVRONevro Corp
11/03/202421h50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NVRONevro Corp
11/03/202421h49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NVRONevro Corp
07/03/202400h25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NVRONevro Corp
05/03/202422h18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NVRONevro Corp
05/03/202422h16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NVRONevro Corp
05/03/202422h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NVRONevro Corp
01/03/202423h56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NVRONevro Corp
01/03/202423h55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NVRONevro Corp
28/02/202422h10PR Newswire (US)Nevro Receives FDA 510(k) Clearance to Use SI Fixation System Without Need to Include Lateral ScrewNYSE:NVRONevro Corp
23/02/202423h08Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNYSE:NVRONevro Corp
22/02/202422h19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NVRONevro Corp
22/02/202422h16Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:NVRONevro Corp
21/02/202422h11Edgar (US Regulatory)Form 8-K - Current reportNYSE:NVRONevro Corp
21/02/202422h09Edgar (US Regulatory)Form 8-K - Current reportNYSE:NVRONevro Corp
21/02/202422h06PR Newswire (US)Nevro Enters Into Cooperation Agreement With Engaged CapitalNYSE:NVRONevro Corp
21/02/202422h05PR Newswire (US)Nevro Reports Fourth-Quarter and Full-Year 2023 Financial ResultsNYSE:NVRONevro Corp
14/02/202421h47Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNYSE:NVRONevro Corp
14/02/202421h38Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNYSE:NVRONevro Corp
01/02/202422h30PR Newswire (US)Nevro Announces Consensus Statement Supporting High-Frequency (10 kHz) Spinal Cord Stimulation Therapy for Refractory Painful Diabetic NeuropathyNYSE:NVRONevro Corp
29/01/202422h30PR Newswire (US)Nevro to Report Fourth-Quarter and Full-Year 2023 Financial Results and Host Conference Call on February 21, 2024NYSE:NVRONevro Corp
 Showing the most relevant articles for your search:NYSE:NVRO

Kürzlich von Ihnen besucht

LSE
HSN
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten